A Pilot Study to Determine the Most Effective Dose of Arformoterol for Treating Acute Asthmatic Patients Presenting to the Emergency Department and to Evaluate Its Side Effect and Safety Profile When Used in This Clinical Situation.

Trial Profile

A Pilot Study to Determine the Most Effective Dose of Arformoterol for Treating Acute Asthmatic Patients Presenting to the Emergency Department and to Evaluate Its Side Effect and Safety Profile When Used in This Clinical Situation.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 13 Apr 2015

At a glance

  • Drugs Arformoterol (Primary) ; Levosalbutamol
  • Indications Asthma; Bronchospasm
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Jun 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 14 Jan 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top